Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
Active, not recruiting · NCT06228404 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Early phase 1 | 2026-07-23 | NCT06228404 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bioray Laboratories | 10 |
| Shanghai Changzheng Hospital | 79 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changzheng hospital | Shanghai | China | 5 |